Skip to Main Content

Paper Details

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.
Proc Natl Acad Sci U S A
765
2017
G4, MERS-CoV, MERS-CoV S ectodomain, Middle East respiratory syndrome coronavirus, coronavirus, coronavirus S proteins, human, prefusion MERS-CoV spike antigen, spike (S) glycoprotein
Author NameAffiliation
Lingshu WangVaccine Research Center, National Institute of Allergy and Infectious Diseases
Mark R DenisonVanderbilt University Medical Center
Mark R DenisonVanderbilt University School of Medicine
James D ChappellVanderbilt University Medical Center
Jason S McLellanGeisel School of Medicine at Dartmouth
  • 1 - 5

Datasets

Release 1.2